The Cosmetic Act in Japan is administered under the broader framework of the Pharmaceutical and Medical Devices Act (PMD Act), which is overseen by the Ministry of Health, Labour and Welfare (MHLW) and implemented through the Pharmaceutical and Medical Devices Agency (PMDA). The main regulations governing cosmetics include the Pharmaceutical and Medical Device Law (latest amendment passed in May 2025) and the Standards for Cosmetics (originally issued on 01/04/2001, with several updates through subsequent notices).
In addition to these, there are more than 10 existing key regulations relevant to cosmetics, such as the “Act for Ensuring Quality, Effectiveness, and Safety of Pharmaceutical and Medical Devices,” which came into force on September 14th, 2019 and continues to be updated. Recent amendments (2025) include strengthened requirements for manufacturing and quality management (GMP), improved supply-stability measures, and updated rules on the labeling of “highlighted ingredients” (特記成分), which now require clearer indication of ingredient purpose and restrict terminology that could imply medical effects.
Furthermore, Japan has enhanced ingredient transparency by aligning cosmetic raw material standards with CAS Registry Numbers (CAS RN) through NITE’s CHRIP database, making it easier for companies to verify ingredient safety and regulatory compliance.
According to Article 2.3 of the Pharmaceutical Affairs Law, “cosmetics” is defined as articles with mild action on the human body which are intended to be applied to the human body through rubbing, sprinkling or other similar methods, aiming to clean, beautify and increase the attractiveness, alter the appearance or to keep the skin or hair in good condition.
Cosmetic products include two main categories in Japan.
The common quasi-drugs product types in Japan include the following:
Ingredients:
A thorough documentation of the active ingredient should be provided to the Pharmacy agency: Pre-Marketing Registration and Approval (PMDA). The agency will fully verify the product and claimed effects and then a specific labelling with the term "quasi drug" will be provided. A monograph is possible to follow for certain products.
The ingredients
"The ingredients of cosmetic products, including the impurities they contain, must not contain anything that could cause infection or make the use of cosmetic products hazardous to health” --Standard for Cosmetics
To help the manufacturers with their formulation, the Cosmetic Act has establish the following documents :
The Label and claims
The labelling should be in Japanese and present the following :
"Codes on Fair Competition regarding the representations of cosmetics" are Volontary standards on labelling and claims which are widely observed in Japan.
A list of 56 accepted efficacy claims for cosmetics is establish to prevent companies from giving unreasonable premiums and misleading representations claims. The Cosmetic Act :